These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30894497)

  • 61. The properties of inhaled corticosteroids: similarities and differences.
    Barnes NC
    Prim Care Respir J; 2007 Jun; 16(3):149-54. PubMed ID: 17530144
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New insights into the pathogenesis and management of steroid-resistant asthma.
    Spahn JD; Leung DY; Szefler SJ
    J Asthma; 1997; 34(3):177-94. PubMed ID: 9168845
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma.
    Andersson O; Cassel TN; Grönneberg R; Brönnegård M; Stierna P; Nord M
    J Allergy Clin Immunol; 1999 Apr; 103(4):595-600. PubMed ID: 10200007
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Refractory asthma: mechanisms, targets, and therapy.
    Trevor JL; Deshane JS
    Allergy; 2014 Jul; 69(7):817-27. PubMed ID: 24773466
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No association of glucocorticoid receptor polymorphisms with asthma and response to glucocorticoids.
    Szczepankiewicz A; Breborowicz A; Sobkowiak P; Popiel A
    Adv Med Sci; 2008; 53(2):245-50. PubMed ID: 18952539
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steroid resistant asthma.
    Luhadia SK
    J Assoc Physicians India; 2014 Mar; 62(3 Suppl):38-40. PubMed ID: 25327059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glucocorticoid Insensitivity in Asthma: The Unique Role for Airway Smooth Muscle Cells.
    Ramos-Ramírez P; Tliba O
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma.
    Choi JS; Jang AS; Lee JH; Park JS; Park SW; Kim DJ; Park CS
    J Korean Med Sci; 2005 Aug; 20(4):586-90. PubMed ID: 16100448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy.
    Albertson TE; Bullick SW; Schivo M; Sutter ME
    Drug Des Devel Ther; 2016; 10():4047-4060. PubMed ID: 28008228
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting Th2 cells in asthmatic airways.
    Caramori G; Ito K; Adcock IM
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):243-55. PubMed ID: 15379592
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
    Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone.
    Rao R; Gregson RK; Jones AC; Miles EA; Campbell MJ; Warner JO
    Eur Respir J; 1999 Jan; 13(1):87-94. PubMed ID: 10836329
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.
    Gavrila A; Chachi L; Tliba O; Brightling C; Amrani Y
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):728-37. PubMed ID: 25897650
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mitogen-activated protein kinases as therapeutic targets for asthma.
    Khorasanizadeh M; Eskian M; Gelfand EW; Rezaei N
    Pharmacol Ther; 2017 Jun; 174():112-126. PubMed ID: 28223227
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma.
    Dal Negro RW; Bonadiman L; Turco P
    Ther Adv Respir Dis; 2018; 12():1753466618789894. PubMed ID: 30215289
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
    van der Velden VH
    Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of fluticasone propionate and comparison with other inhaled corticosteroids.
    Johnson M
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S434-9. PubMed ID: 9563368
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Limitations of corticosteroid effects in asthma: biochemical approach.
    Lane SJ; Lee TH
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):635-9. PubMed ID: 8124303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.